10:00—11:30 AM
The Brookings Institution
1775 Massachusetts Ave NW
Falk Auditorium
Washington, DC 20036

Spurring Private Investment in Health R&D around the World

This event will be held at the Brookings Institution and features CGD expert Amanda Glassman.

Private investment in health R&D by pharmaceutical companies, charitable foundations, and venture capital firms, among others, can help to save lives and boost the health of entire regions. But some countries’ health governance infrastructures, management capacities, regulatory processes, and policy conditions are better equipped to utilize this private funding than others. What governance factors promote an investment-friendly environment for the private sector? And how can countries attract more private sector health financing?

On March 30, Governance Studies at Brookings will host a panel of experts to discuss what conditions lead to good health governance and how those conditions affect a country’s ability to use private investments in health R&D. At the event, authors Darrell West and John Villasenor will release their new paper, “Health governance capacity: Enhancing private sector investment in global health,” which examines 18 countries throughout Asia and sub-Saharan Africa. How compatible is each country’s health governance strategy with effective use of private investment in R&D?"


John Villasenor, Nonresident Senior Fellow, Governance Studies, Center for Technology Innovation, The Brookings Institution

Key Findings and Recommendations

Darrell West, Vice President and Director, Governance Studies; Founding Director, Center for Technology Innovation, The Brookings Institution

Panel discussion

John VillasenorNonresident Senior Fellow, Governance Studies, Center for Technology Innovation, The Brookings Institution

Loyce Pace, President & Executive Director, Global Health Council

Amanda Glassman, Chief Operating Officer and Senior Fellow, Center for Global Development


Subscribe today to receive CGD’s latest newsletters and topic updates.